04:51 PM EDT, 09/11/2025 (MT Newswires) -- Amir Nashat, 10% Owner, Director, on September 11, 2025, executed a purchase for 1,307,189 shares in Camp4 Therapeutics ( CAMP ) for $1,999,999. Following the Form 4 filing with the SEC, Nashat has control over a total of 1,106,751 common shares of the company, with 1,106,751 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1736730/000119312525201380/xslF345X05/ownership.xml